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Rapid targeting of nuclear proteins to the cytoplasm
Juli D. Klemm, Chan R. Beals* and Gerald R. Crabtree
Background: The transcription factor NF-ATc plays a key role in the activation
of many early immune response genes and is regulated by subcellular
localization. NF-ATc translocates from the cytoplasm to the nucleus in response
to a rise in intracellular calcium, and immediately returns to the cytoplasm when
intracellular calcium levels fall. The rapid nuclear exit of NF-ATc is thought to be
one mechanism by which cells distinguish between sustained and transient
calcium signals. 
Results: To study the nuclear export of NF-ATc, we have developed a general,
non-invasive assay for the identification and study of nuclear export signals
(NESs). The NES is defined by its ability to translocate a protein from the
nucleus to the cytoplasm when the two are tethered by a membrane-permeable
ligand. This procedure has allowed us to identify a NES within NF-ATc that
functions in concert with a glycogen synthase kinase-regulated process to
direct the rapid nuclear exit of NF-ATc. 
Conclusions: The rapid nuclear export of NF-ATc via its NES and a glycogen
synthase kinase-regulated event may be an important mechanism for insulating
cells from transient spikes in intracellular calcium which might otherwise lead to
inappropriate activation. The assay we have developed allows the rapid
identification of NESs and can be used as a general method for the inducible
cytoplasmic export of nuclear proteins.
Background
Members of the NF-AT family of transcription factors are
expressed in most tissues, and in lymphocytes they appear
to participate in the activation of immune responses. NF-
ATc is expressed predominantly in lymphoid tissues and
is involved in the activation of early response genes,
including interleukin-2 (IL-2), IL-4, CD40 ligand and Fas
ligand [1–6]. In resting cells, NF-ATc is located in the
cytoplasm; antigen receptor stimulation initiates Ca2+
signals that lead to the rapid translocation of NF-ATc to
the nucleus [7–9]. The drugs cyclosporin A and FK506
exert their immunosuppressive effects by inhibiting
calcineurin, a Ca2+-sensitive serine/threonine protein
phosphatase [10], leading to a block in the nuclear translo-
cation of NF-ATc [7]. Upon termination of Ca2+ signaling,
NF-ATc is exported rapidly to the cytoplasm [9], and it is
this opposing activity that makes NF-ATc exquisitely
sensitive to the duration of Ca2+ fluxes [9,11].
The processes that influence the subcellular localization
of NF-ATc are beginning to be understood. In resting
cells, the amino terminus of NF-ATc is phosphorylated at
multiple serines; the dephosphorylation of NF-ATc by
Ca2+-activated calcineurin leads to the unmasking of two
nuclear localization signals (NLSs) and the translocation of
the protein to the nucleus [12]. This process appears to be
opposed by the NF-ATc kinase, glycogen synthase
kinase-3 (GSK-3), the overexpression of which blocks the
Ca2+-dependent nuclear translocation of NF-ATc [13].
The rapid exit of the protein from the nucleus upon termi-
nation of Ca2+ signaling suggests that NF-ATc contains a
nuclear export sequence (NES), but such a sequence has
not yet been identified.
Other proteins that shuttle between the nucleus and the
cytoplasm contain specific NESs; such proteins include
human immunodeficiency virus-1 (HIV-1) Rev [14],
cAMP-dependent protein kinase inhibitor (PKI) [15],
RanBP1 [16], TFIIIA [17] and perhaps IkB [18]. These
short sequences contain repeats of hydrophobic residues
of defined spacing [19,20]. The ability of these sequences
to mediate rapid nuclear export of linked proteins when
microinjected into the nucleus demonstrates that they
are necessary and sufficient for the rapid export of pro-
teins from the nucleus [14,15,17]. Nuclear export, like
nuclear import, is temperature-dependent and energy-
dependent, and the export of a protein with a NES is
much faster than the slow nuclear egress of proteins
lacking this element [14,15,21]. Although NESs bear no
resemblance to classical NLSs, evidence indicates that
protein export proceeds through the same nuclear pores as
protein import [22]. NESs, like NLSs, direct an associa-
tion with proteins that are part of the nuclear pore struc-
ture, and are one of the many sequence elements used by
cells to specify protein trafficking.
Address: Howard Hughes Medical Institute,
Department of Developmental Biology, Stanford
University School of Medicine, Stanford, California
94305, USA.
*Present address: Icos Corporation, Bothell,
Washington 98021, USA.
Correspondence: Gerald R. Crabtree
E-mail: hf.grc@forsythe.stanford.edu
Received: 14 May 1997
Revised: 9 July 1997
Accepted: 10 July 1997
Published: 8 August 1997
Current Biology 1997, 7:638–644
http://biomednet.com/elecref/0960982200700638
© Current Biology Ltd ISSN 0960-9822
To study the rapid export of NF-ATc, we have developed
a general method to inducibly link an export signal to a
nuclear protein. We have used this procedure to identify a
sequence in NF-ATc that mediates nuclear export in this
assay. Mutations in this sequence interfere with the rapid
nuclear exit of NF-ATc normally seen upon termination
of Ca2+ signaling, demonstrating that it is a functional
NES. Our new assay not only allows for the rapid identifi-
cation of NESs, but also provides a general method for the
inducible export of nuclear proteins to the cytoplasm.
Results 
A general assay for the identification of nuclear export
signals
To identify the signals within NF-ATc that direct its export
from the nucleus, we developed a method to rapidly screen
short peptide sequences for their ability to mediate nuclear
export (Figure 1). In this assay, a small protein containing a
potential NES is conditionally linked to a protein localized
to the nucleus by virtue of a NLS. Functional NESs are
identified by their ability to direct export of the nuclear
protein. The conditional linkage is mediated by rapamycin,
a membrane-permeable macrolide that binds the
immunophilin FK506-binding protein-12 (FKBP12)
[23,24]. The FKBP12–rapamycin (FR) complex interacts
with the FR-binding (FRB) domain of the FR-associated
protein (FRAP) [25,26]. Two chimeric proteins, one con-
taining FKBP12 and the other containing the FRB domain,
can thus be linked in cells by the addition of rapamycin.
As a first test of the assay, we constructed two plasmids:
the first contained a sequence encoding the 12 amino acid
NES of the Rev protein fused to the FRB domain and
marked with a hemagglutinin (HA) epitope tag
(FRB–Rev); the second contained a sequence encoding
the Gal4 DNA-binding domain and a NLS linked to three
repeated FKBP12 domains and marked with a FLAG
epitope tag (Gal4–FKBP). The proteins were co-expressed
in COS-7 cells, and the subcellular localization of
Gal4–FKBP and FRB-Rev was visualized by indirect
immunofluorescence. In the absence of rapamycin,
Gal4–FKBP was localized to the nucleus, whereas
FRB–Rev — small enough (~11.5 kD) to diffuse freely
through the nuclear pores — was expressed diffusely in
both the nucleus and the cytoplasm (Figure 2a). Strik-
ingly, within 1 hour of the addition of rapamycin, both
proteins become localized to the cytoplasm in approxi-
mately 80% of the cells (Figure 2a,b). Relocalization was
dependent upon the presence of both proteins. Export did
not occur at 4°C (Figure 2a) or in the presence of sodium
azide (data not shown), indicating that this assay measures
an energy-dependent process. Moreover, export was not
inhibited by the protein-synthesis inhibitor anisomycin
(data not shown), indicating that dynamic protein relocal-
ization, rather than an altered localization of newly synthe-
sized proteins, was being measured. 
Further studies using other NESs were carried out to test
the generality and sensitivity of the assay. When point
mutations were introduced into the NES of the FRB–Rev
chimera — producing a variant corresponding to the
dominant-negative Rev M10 mutant [27] — export of
Gal4–FKBP was not promoted upon addition of rapamycin
(Table 1). Instead, in the presence of rapamycin,
FRB–RevM10 accumulated in the nucleus with
Gal4–FKBP (Figure 2a). When the 13 amino acid NES
peptide from PKI [15] was fused to the FRB domain,
export of Gal4–FKBP was directed in a rapamycin-
dependent manner. Point mutations in this sequence pre-
viously shown to block PKI export [15] also blocked export
in this assay (Table 1). The sensitivity of this assay to
mutations thus suggested that the method could be used in
the identification of novel export sequences.
To test whether the rapamycin-inducible system could be
used as a general method to relocalize a nuclear protein to
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Figure 1
Overview of the rapamycin-mediated nuclear
export assay. The DNA-binding domain and
NLS of Gal4 (amino acids 1–147) are linked
to tandem repeats of the immunophilin
FKBP12 and coexpressed with a fusion
protein consisting of the FKBP–rapamycin-
binding domain of FRAP (FRB) linked to a
putative NES. The small size of the FRB–NES
chimera (~11.5 kDa) allows it to diffuse freely
through the nuclear pores. Rapamycin (rap)
mediates a high-affinity interaction between
FKBP12 and the FRB domain that is of
sufficient stability to allow export of the Gal4-
FKBP chimera from the nucleus via the
associated NESs.
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the cytoplasm, we constructed a chimeric protein contain-
ing the dimerization and DNA-binding domain of hepato-
cyte nuclear factor-1α — HNF-1α; a dimer with a
molecular weight of ~62 kD [28] — fused to three
FKBP12 domains. This protein became localized to the
cytoplasm in a rapamycin-dependent manner when coex-
pressed with FRB–Rev (Figure 2c), demonstrating that
the FRB–rapamycin–FKBP interaction is of sufficient sta-
bility to allow NES-directed transport of large protein
complexes from the nucleus to the cytoplasm. 
Identification of a nuclear export sequence in NF-ATc by
the ligand-mediated export assay
Sequences from NF-ATc were tested for their ability to
mediate cytoplasmic relocalization in the ligand-mediated
export assay. Most export sequences identified to date are
hydrophobic, containing a leucine every 2–3 residues
[19,20], although the sequences tolerate significant alter-
ation [29]. Candidate sequences from NF-ATc were fused
to the FRB domain and assayed for their ability to mediate
export of Gal4–FKBP in the presence of rapamycin
(Table 1). Of the 10 such sequences tested, one,
SAIVAAINALTT, corresponding to amino acids 310–321,
acted as a NES in our assay. To verify the specificity of
this sequence, we tested two mutant sequences (Table 1):
one in which the isoleucines at positions 312 and 316 were
changed to alanine (I312A/I316A), and one in which
isoleucine 316 and leucine 319 were changed to alanine
(I316A/I319A). Neither of these variants was able to
mediate export, suggesting that these residues are
essential for promoting export. 
Mutation of the putative export signal within NF-ATc
impedes nuclear exit 
Amino-acid substitutions in the sequence corresponding
to residues 310–321 of NF-ATc revealed that this region is
required for the rapid nuclear export of the protein.
Isoleucine 316 and leucine 319 of NF-ATc were both
changed to alanine and the nucleus-to-cytoplasm translo-
cation of this mutant protein was examined by indirect
immunofluorescence (Figure 3a). In the absence of stimu-
lation, both wild-type NF-ATc and NF-ATcI316A/L319A
were located in the cytoplasm. When stimulated with Ca2+
ionophore, both proteins translocated to the nucleus in
approximately 75% of cells. To examine export of these
proteins, we terminated Ca2+ signaling by replacing the
medium with medium containing FK506 (an inhibitor of
calcineurin [10]), and recorded the protein localization
after 20, 40 and 60 minutes. Strikingly, 20 minutes after
the termination of Ca2+ signaling, wild-type NF-ATc was
relocalized to the cytoplasm in nearly all cells, whereas
NF-ATcI316A/L319A remained in the nucleus (Figure 3a,b).
Sixty minutes after termination of Ca2+ signaling, NF-
ATcI316A/L319A remained in the nucleus in approximately
50% of transfected cells (Figure 3b). We conclude that
amino acids 310–321, first identified as a potential NES in
the rapamycin-inducible export assay, encode a functional
NES in the context of the NF-ATc protein.
To ensure that the impaired nuclear exit of
NF-ATcI316A/L319A was due to disruption of an export
signal, we tested this mutant protein for other possible
sources of nuclear retention. First, we compared the phos-
phorylation states of the wild-type and mutant proteins
upon ionophore treatment and soon after termination of
Ca2+ signaling. This study revealed that both wild-type
NF-ATc and NF-ATcI316A/L319A were rapidly dephospho-
rylated during Ca2+ stimulation and then rephosphorylated
upon termination of signaling (Figure 3c). Moreover, muta-
tion of the NES did not significantly affect the transloca-
tion of NF-ATc to the nucleus upon addition of ionophore,
demonstrating that the slow nuclear export of this variant
does not reflect increased nuclear import. Finally, NF-
ATcI316A/L319A was capable of activating NF-AT-depen-
dent transcription (data not shown), demonstrating that its
slow nuclear export is not due to denaturation of the
mutant protein. 
Although mutation of the NES slowed the nuclear export
of NF-ATc dramatically, exit from the nucleus was not
blocked completely (Figure 3b). Nuclear export of
NF-ATc has been shown to be enhanced by overexpres-
sion of GSK-3, which phosphorylates the conserved
serines that control nuclear entry of the protein [13], and
nuclear export is slowed by the GSK-3 inhibitor, lithium
([30,31] and our unpublished observations). We therefore
Table 1
Sequences tested for their ability to direct nuclear export of
Gal4–FKBP in the rapamycin-mediated export assay.
Source of NES Sequence Export
REV LQLPPLERLTLD +
m10Rev -----DL----- –
PKI LALKLAGLDINKT +
mPKI ----A--A----- –
NF-ATc 310–321 SAIVAAINALTT +
m310–321-1 ------A--A-- –
m310–321-2 --A---A----- –
NF-ATc 115–129 LESPRIEITSCLGFY –
NF-ATc 154–165 TATLSLPSLEAY –
NF-ATc 324–334 SLDLGDGVPVK –
NF-ATc 345–358 SVALKVEPVGEDLG –
NF-ATc 412–420 LPALDWQLP –
NF-ATc 470–480 EPLMLQLFIGT –
NF-ATc 655–665 SLVVEIPPFRN –
NF-ATc 669–677 TSPVHVSFY –
Amino-acid sequences were tested for nuclear export activity by linking
them to the carboxyl terminus of the FRB domain and coexpressing
them with Gal4-FKBP in COS-7 cells. Cells were treated with
rapamycin (5 ng/ml) for 2 h and the nuclear export of Gal4-FKBP
identified by indirect immunofluorescence. Hydrophobic residues are
highlighted with bold print. Sequences that lead to nuclear exclusion of
Gal4-FKBP following addition of rapamycin are marked with a ‘+’. 
examined whether the slow nuclear export of NF-
ATcI316A/L319A could be inhibited by lithium. Strikingly,
lithium further inhibited the nuclear export of
NF-ATcI316A/L319A (Figure 3b). Lithium does not impair
the nuclear import of NF-ATc, nor does it affect the
nuclear export of other proteins (our unpublished observa-
tions), demonstrating that this result is specific to its
action on NF-ATc. Thus, nuclear export of NF-ATc is
controlled both by the NES and by a lithium-sensitive
process, which is likely to be mediated by GSK-3. 
Discussion
NF-ATc contains a signal for rapid nuclear export
The NF-AT family of transcription factors play central
roles in activation of the immune system; thus, proper
control of their activity is critical to mounting a regulated
Research Paper  Ligand-mediated nuclear export assay Klemm et al.    641
Figure 2
Rapamycin induces nuclear export of FRB–NES and NLS–FKBP-
containing fusion proteins. (a) Subcellular localization of the
FRB–REV and Gal4–FKBP fusion proteins transiently co-expressed
in COS-7 cells that were unstimulated (left panels) or that had been
treated with rapamycin (5 ng/ml) for 2 h (right panels). For each
experiment shown, cells had been cotransfected with a HA-tagged
FRB–NES chimera and a FLAG-tagged Gal4–FKBP chimera. First
row: localization of the fusion protein containing the FRB domain
fused to the NES of HIV-1 Rev (FRB–REV), cotransfected with
Gal4–FKBP. Second row: localization of Gal4–FKBP cotransfected
with FRB–REV. Third row: localization of the FRB–NES chimera
containing a mutant Rev NES (FRB–mREV), cotransfected with
Gal4–FKBP. Fourth row: localization of Gal4–FKBP cotransfected
with FRB–mREV. Fifth row: localization of FRB–REV cotransfected
with Gal4–FKBP at 4°C. (b) Timecourse of rapamycin-mediated
nuclear export. FLAG-tagged Gal4–FKBP and HA-tagged FRB–REV
were co-transfected into COS-7 cells at either a 3:1 or 1:3 ratio,
such that the fusion protein visualized in the experiment was limiting.
Cells localizing the protein in the cytosol were determined as a
percentage of expressing cells at the indicated times following
rapamycin addition. (c) HNF1–FKBP chimera is exported from the
nucleus. The DNA-binding domain and NLS of HNF-1α (amino acids
1–282) were linked to tandem repeats of FKBP12 and transiently
co-expressed in COS-7 cells with FRB–REV. Left panel: localization
of HNF1–FKBP in unstimulated cells. Right panel: localization of
HNF1–FKBP in cells treated with rapamycin (5 ng/ml) for 2 h. 
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immune response. NF-ATc translocates to the nucleus in
response to Ca2+ signals initiated at the antigen receptor,
and rapidly returns to the cytoplasm when Ca2+ levels fall
[7–9]. Evidence suggests that subcellular compartmental-
ization is the major mechanism by which NF-AT family
members are regulated. Most notably, deliberate nuclear
localization of NF-AT bypasses the need for a Ca2+
stimulus to initiate NF-AT-dependent transcription and
IL-2 production, and renders Jurkat T lymphocytes
resistant to the action of cyclosporin A [9]. Here, we show
that NF-ATc contains a NES that is required for the
immediate return of NF-ATc to the cytoplasm upon inac-
tivation of calcineurin, which should lead to the rapid
down-regulation of NF-ATc-directed transcription upon
termination of antigen receptor signaling.
Rises in intracellular calcium occur as sustained elevations,
transient spikes or oscillations [32], and the rapid nuclear
export of NF-ATc is one mechanism for cells to dis-
criminate among these calcium signaling patterns. Nuclear
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Figure 3
Identification of a NES in NF-ATc. (a) The NES of NF-ATc is required
for efficient nuclear export. Wild-type NF-ATc bearing an amino-terminal
FLAG epitope tag and a version of the protein containing the
I316A/I319A mutations (NF-ATmNES) were expressed in COS-7 cells.
Protein localization was visualized by indirect immunofluorescence in
unstimulated cells (NS; top panels), cells stimulated with ionomycin
(2 µm) and calcium (10 mM) for 60 min (I + Ca2+; center panels), and
cells stimulated with I + Ca2+ for 60 min and then changed to media
containing FK506 for 20 min to terminate calcineurin-dependent
signaling (I + Ca2+→FK; bottom panels). (b) NF-ATc nuclear export is
blocked by mutation of the NES and treatment with the GSK-3 inhibitor
lithium. Wild-type NF-ATc or NF-ATmNES were transiently expressed in
COS-7 cells and the cells treated with ionomycin (2µM) and calcium
(10 mM) for 60 min to localize NF-ATc to the nucleus. Calcineurin-
dependent signaling was terminated by replacing the medium with
medium containing FK506 (10 ng/ml) or FK506 plus lithium (5 mM ) for
the indicated times. The percentage of expressing cells with
cytoplasmic NF-ATc or NF-ATmNES  was determined by indirect
immunofluorescence. (c) NF-ATc and NF-ATmNES are
dephosphorylated and rephosphorylated in a similar manner. NF-ATc
and NF-ATmNES were transiently expressed in COS-7 cells and the
cells were treated with ionomycin and calcium as described in 
(b). Calcineurin-dependent signaling was terminated as described in
(b). After the indicated times, lysates were prepared, subjected to
SDS/PAGE, and immunoblotted with an anti-FLAG monoclonal
antibody. Dephosphorylation of NF-ATc and NF-ATmNES upon calcium
stimulation is indicated by the increased mobility of the protein.
Rephosphorylation upon termination of calcium signaling is indicated by
decreased electrophoretic mobility after 5 min and 10 min of FK506
treatment. The heterogeneous mobilities of the NF-ATc and
NF-ATmNES proteins are likely to reflect the heterogeneous
phosphorylation states of these multiply-phosphorylated proteins. 
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localization of NF-ATc requires sustained Ca2+ elevation,
as a brief Ca2+ spike evokes only temporary nuclear translo-
cation of NF-ATc [9,11]. The concerted actions of the NES
and GSK-3 rapidly remove NF-ATc from the nucleus, insu-
lating cells from transient spikes in intracellular calcium
that might otherwise lead to inappropriate activation. 
A new method for the identification of nuclear export signals
We have developed a sensitive and general method for the
identification of NESs. The method is rapid and does not
require the integrity of the cytoplasmic and nuclear mem-
branes to be perturbed. Moreover, the equipment, tech-
niques and reagents required are widely available. This
system has also been shown to function in Jurkat T lym-
phocytes (R. Briesewitz and G.R.C., unpublished observa-
tions), demonstrating that it should be useful in multiple
cell types. We show here that our assay recapitulates results
obtained from microinjection studies: the export signals
from HIV-1 Rev and PKI promote export in our assay, and
this export is temperature-dependent and energy-depen-
dent. Therefore, our method should be useful to study the
mechanism of nuclear export and to screen for agents and
proteins that selectively inhibit this process. Using our
approach, export can be visualized on a cell-by-cell basis
and even a negative result is unambiguous, as constructs
with nonfunctional export signals are seen to accumulate in
the nucleus. Finally, our method permits precise control
over the timing and level of export by adjusting the
concentration and duration of rapamycin treatment. 
Cell-permeable inducers of dimerization have been used
previously to recruit proteins to the plasma membrane
[33–35], to activate transcription [36], and to induce nuclear
localization of a diffusible protein [37]. We have used
rapamycin as a cell-permeable ligand for the attachment of
an export signal to a nuclear protein. The inducible cytoso-
lic relocalization of a nuclear protein implies that it should
be possible to inhibit the function of a transcription factor or
a nuclear protein by inducibly relocalizing it to the cyto-
plasm. Alternatively, a protein that normally translocates to
the nucleus could be retained in the cytoplasm by tethering
it to an exogenous export signal. The ability to inducibly
regulate protein function in this manner should have broad
application for the study of many biological processes.
Conclusions
Our studies reveal that the T-lymphocyte transcription
factor NF-ATc contains a sequence that is involved in
directing rapid exit of the protein from the nucleus upon
termination of Ca2+ signaling. This NES was identified
using a new assay, in which short sequences can be rapidly
screened for their ability to direct export of a nuclear
protein when attached by a cell-permeable ligand. This
assay should not only prove useful in further studies of
protein nuclear export, but should also be generally useful
for the inducible relocalization of nuclear proteins. 
Materials and methods
Plasmid constructs
Mammalian expression constructs were based on the pBJ5 vector, a
derivative of pCD-SRα. Gal4–FKBP and HNF1–FKBP were gifts of B.
Cunningham and S. Ho, respectively. FRB-NES plasmids contained
the FKBP-rapamycin binding domain (Mr 11K) from FRAP [26] and the
HA epitope tag. NESs were synthesized as complementary oligo-
nucleotides and inserted between the FRB and HA elements. NF-ATc
expression constructs were based on pSH160c [12] and contain a
FLAG epitope tag at the amino terminus of the protein. The
I316A/L319A mutations in this construct were created by sequential
overlap extension PCR [38]. 
Cell culture, transfection and stimulation
COS-7 cells were maintained in DMEM and transfected as described
previously [12]. 18–24 h post-transfection, cells were stimulated in
media supplemented with drugs. For FRB–FKBP recruitment studies,
cells were treated with 5 ng/ml rapamycin (a generous gift of Suran
Sehgal, Wyeth-Aryest) for 2 h at 37°C to promote the interaction
between the FRB and FKBP fusion proteins. To study the temperature
dependence of ligand-mediated nuclear export, cells were transfected
and stimulated as usual and rapamycin was added to cells placed on
ice. For studies of the affect of sodium azide on export, transfected
cells were treated for 15 min with glucose-free DMEM containing 6 mM
2-deoxyglucose, 10% dialyzed fetal calf serum, and 10 mM sodium
azide, after which rapamycin was added. For export studies in the pres-
ence of anisomycin, cells were pre-treated with 50 µM anisomycin for
10 min, then with anisomycin and rapamycin for 2 h. This concentration
of anisomycin was shown to block >98% of protein synthesis in
COS-7 cells, as measured by 35S-methionine incorporation. 
For NF-ATc translocation studies, cells were stimulated with 2 µM ion-
omycin (Calbiochem) and 10 mM CaCl2 for 1 h to promote import;
Ca2+ stimulation was terminated by replacing the medium with medium
containing 10 µg/ml FK506 (a gift from Fujisawa, Chicago). Studies of
the effect of GSK-3 inhibition on NF-ATc export were performed as
described above, with the addition of 5 mM LiCl (Sigma) to the FK506-
containing medium (our unpublished data).
Immunofluorescence
Cells were fixed, permeabilized, and stained as described previously
[12]. At least 100 expressing cells were scored on each coverslip. Trans-
fected cells in which the nucleus and plasma membrane could be identi-
fied were scored as containing predominantly cytoplasmic staining,
predominantly nuclear staining, or both cytoplasmic and nuclear staining.
Phosphorylation analysis
Wild-type NF-ATc and NF-ATmNES  were transiently expressed in
COS-7 cells and the cells were treated with ionomycin and calcium as
described above. Calcineurin-dependent signaling was terminated by
addition of FK506 as described above. 5 min and 10 min after addition
of FK506, the media was aspirated from the cells and 200 µl SDS
PAGE loading buffer at 80°C was added immediately. This extract was
boiled for 8 min, electrophoresed on an 8% acrylamide gel (bis-acry-
lamide:acrylamide 1:100), and electroblotted to nitrocellulose. The blot
was probed with the anti-FLAG M2 monoclonal antibody (Kodak) and
horseradish peroxidase-conjugated rabbit anti-mouse IgG, and the
proteins were visualized by ECL (Amersham). 
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